Lv1
38 积分 2022-05-23 加入
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
5天前
已完结
Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability
3个月前
已完结
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
4个月前
已完结
Recent Advances in Smart Linkage Strategies for Developing Drug Conjugates for Targeted Delivery
4个月前
已完结
Approaches to Improve the Translation of Safety, Pharmacokinetics and Therapeutic Index of ADCs
5个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
5个月前
已完结
PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review
6个月前
已完结
The medicinal chemistry evolution of antibody–drug conjugates
7个月前
已完结
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
8个月前
已完结
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders
11个月前
已完结
皖公网安备34019202002308
